SNWV — SANUWAVE Health Cashflow Statement
0.000.00%
- $133.87m
- $143.88m
- $44.05m
Annual cashflow statement for SANUWAVE Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -27.3 | -10.3 | -25.8 | -31.4 | 11.8 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 9.87 | -6.71 | 17.5 | 32.2 | -4.9 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 9.72 | -1.12 | 2.7 | 0.484 | -4.01 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -6.41 | -17.2 | -4.54 | 2.46 | 3.88 |
| Capital Expenditures | -0.529 | — | — | -0.49 | -1.94 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | 0.332 | 0.021 | 0 | 5.38 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale of Intangible Assets | |||||
| Cash from Investing Activities | -0.529 | 0.332 | 0.021 | -0.49 | 3.43 |
| Financing Cash Flow Items | 1.74 | 0.695 | -0.639 | -1.49 | -0.371 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 5.12 | 17.4 | 5.21 | 6.35 | -5.59 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.82 | 0.534 | 0.644 | 8.44 | 1.72 |